Chiba H, Ichikawa-Tomikawa N, Imura T, Sugimoto K. The region-selective
regulation of endothelial claudin-5 expression and signaling in brain health
and disorders. J Cell Physiol. 2021
Sugimoto K, Chiba H. The claudin-transcription factor signaling pathway.
Tissue Barriers. 2021
Kojima M, Sugimoto K, Kobayashi M, Ichikawa-Tomikawa N, Kashiwagi K, Watanabe
T, Soeda S, Fujimori K, Chiba H. Aberrant Claudin-6-Adhesion Signaling
Promotes Endometrial Cancer Progression via Estrogen Receptor α. Mol Cancer
Res. 2021
Watanabe M, Higashi T, Ozeki K, Higashi AY, Sugimoto K, Mine H, Takagi
H, Ozaki Y, Muto S, Okabe N, Matsumura Y, Hasegawa T, Shio Y, Suzuki H,
Chiba H. CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.
Sci Rep. 2021
Yamashita R, Tanaka M, Chiba H, Sugimoto K. Bacterial Myocarditis in a
Patient with Cancer. JMA J. 2021
Rahman A, Kobayashi M, Sugimoto K, Endo Y, Kojima M, Furukawa S, Watanabe
T, Soeda S, Hashimoto Y, Fujimori K, Chiba H. Reduced Claudin-12 Expression
Predicts Poor Prognosis in Cervical Cancer. Int J Mol Sci. 2021
Yamazaki M, Sugimoto K, Mabuchi Y, Yamashita R, Ichikawa-Tomikawa N, Kaneko
T, Akazawa C, Hasegawa H, Imura T, Chiba H. Soluble JAM-C Ectodomain Serves
as the Niche for Adipose-Derived Stromal/Stem Cells. Biomedicines. 2021
Sugimoto K, Ichikawa-Tomikawa N, Nishiura K, Kunii Y, Sano Y, Shimizu F,
Kakita A, Kanda T, Imura T, Chiba H. Serotonin/5-HT1A Signaling in the
Neurovascular Unit Regulates Endothelial CLDN5 Expression. Int J Mol Sci.
2020
Kojima M, Sugimoto K, Tanaka M, Endo Y, Kato H, Honda T, Furukawa S, Nishiyama
H, Watanabe T, Soeda S, Fujimori K, Chiba H. Prognostic Significance of
Aberrant Claudin-6 Expression in Endometrial Cancer. Cancers. 2020
Higashi T, Chiba H. Molecular organization, regulation and function of
tricellular junctions. Biochim Biophys Acta Biomembr. 2020
Sugimoto K, Ichikawa-Tomikawa N, Kashiwagi K, Endo C, Tanaka S, Sawada
N, Watabe T, Higashi T, Chiba H. Cell adhesion signals regulate the nuclear
receptor activity. Proc Natl Acad Sci USA . 2019
Kashiwagi K, Yanagida M, Matsui D, Tanaka M, Sugimoto K, Chen H, Ichikawa-Tomikawa N, S. Marubashi, H. Suzuki, H. Chiba. Expression of liver X receptors in normal and refractory carcinoma tissues of the human lung and pancreas. Histol Histopathol. 2017
[Review article] Ichikawa-Tomikawa N, Sugimoto K, Satohisa S, Nishiura K, Chiba H. Possible involvement of tight junctions, extracellular matrix and nuclear receptors in epithelial differentiation. J Biomed Biotechnol. 2011
[Review article] Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008
Chiba H, Chambon P, Metzger D. 2000. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.Exp Cell Res. 260:334–339. doi:10.1006/excr.2000.5022.